Pfizer/BioNTech, which has developed the vaccine that is used in the Faroe Islands among others, has announced that they will likely know whether the vaccine protects against the Omicron variant, at the latest in two weeks.
Pfizer/BioNTech, sum hevur ment koppingarevnið, sum m.a. verður brúkt í Føroyum, hevur boðað frá, at tey helst vita, um koppingarevnið verjir ímóti Omkron-frábrigdinum, í seinasta lagi um tvær vikur.